Cellares Names Ali Soleymannezhad as CCO to Drive Global Expansion and IPO Prep
Cellares Appoints Ali Soleymannezhad as Chief Commercial Officer to Lead Global IDMO Expansion and Drive Cell Therapy Access Cellares, the pioneering Integrated Development and Manufacturing Organization (IDMO) transforming the cell…
Vistagen Announces Appointment of Nick Tressler as Chief Financial Officer
Vistagen Appoints Nick Tressler as Chief Financial Officer, Strengthening Leadership Team Amid Growth and Clinical Milestones Vistagen Therapeutics, Inc. a late clinical-stage biopharmaceutical company focused on pioneering neuroscience innovations through…
Octave Bioscience Partners with Quest Diagnostics to Expand MSDA Test Access
Octave Bioscience Partners with Quest Diagnostics to Expand Nationwide Access to MSDA Test Octave Bioscience, a commercial-stage precision care company at the forefront of redefining disease management in multiple sclerosis…
Omeros Corporation Finalizes Asset Purchase and License Agreement with Novo Nordisk for MASP-3 Inhibitor Zaltenibart
Omeros Corporation Announces Completion of Asset Purchase and License Agreement with Novo Nordisk for Zaltenibart a Late-Stage MASP-3 Inhibitor Omeros Corporation today announced the successful closing of its previously disclosed…
Mirum Pharmaceuticals Begins BLOOM Phase 2 Trial with First Patient Dosed Evaluating MRM-3379 for Fragile X Syndrome
Mirum Pharmaceuticals Enrolls First Participant in BLOOM Phase 2 Study Evaluating MRM-3379 for Fragile X Syndrome Mirum Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and delivering innovative therapies for…
Incyte Names Richard Hoffman Executive Vice President and General Counsel
Incyte Announces Appointment of Richard Hoffman as Executive Vice President and General Counsel Incyte today announced that Richard Hoffman has officially assumed the role of Executive Vice President and General…
Circle Pharma Announces Appointment of Dr. Anne E. Borgman as CMO
Circle Pharma Appoints Anne E. Borgman, M.D., as Chief Medical Officer, Strengthening Leadership Team to Advance Next-Generation Macrocycle Oncology Pipeline Circle Pharma, Inc., a clinical-stage biopharmaceutical company advancing a new…
Agilent Unveils 21 CFR Part 11–Compliant Software for xCELLigence RTCA eSight
Agilent Launches Compliance Software for xCELLigence RTCA eSight to Meet 21 CFR Part 11 Standards Agilent Technologies Inc., a global leader in analytical instrumentation, diagnostics, and scientific innovation, has announced…
TeamBest Global Issues Open Letter to AROI on Affordable Cancer and Vascular Care
TeamBest Global Calls for Stronger Collaboration with AROI to Advance Affordable Cancer and Vascular Disease Care in India and Worldwide Dr. Krishnan Suthanthiran, along with his TeamBest Global family of…
Celltrion Wins Health Canada Approval for Eydenzelt Biosimilar
Celltrion Receives Health Canada Approval for Eydenzelt®, a Biosimilar Referencing Eylea® Celltrion, Inc. has announced a major regulatory milestone with the approval of Eydenzelt® by Health Canada. The newly approved…
African Leaders Urge Stronger Health Systems at ICASA 2025
AHF and Society for AIDS in Africa Convene High-Level Summit to Advance Regional Health Leadership and Sustainable Health Financing in Africa at ICASA 2025 The AIDS Healthcare Foundation (AHF) Global…
Corstasis and Cardiovascular Logistics Partner to Advance Outpatient Heart Failure Care
Corstasis Partners with Cardiovascular Logistics to Redefine Heart Failure Treatment Corstasis Therapeutics Inc., a commercial-stage biopharmaceutical company focused on advancing patient-centric, outpatient treatment strategies for cardiovascular and renal disorders, today…